APA (7th ed.) Citation

Jodele, S., Dandoy, C. E., Aguayo-Hiraldo, P., Lane, A., Teusink-Cross, A., Sabulski, A., . . . Davies, S. M. (2024). A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation–associated TMA. Blood, 143(12), 1112-1123. https://doi.org/10.1182/blood.2023022526

Chicago Style (17th ed.) Citation

Jodele, Sonata, et al. "A Prospective Multi-institutional Study of Eculizumab to Treat High-risk Stem Cell Transplantation–associated TMA." Blood 143, no. 12 (2024): 1112-1123. https://doi.org/10.1182/blood.2023022526.

MLA (9th ed.) Citation

Jodele, Sonata, et al. "A Prospective Multi-institutional Study of Eculizumab to Treat High-risk Stem Cell Transplantation–associated TMA." Blood, vol. 143, no. 12, 2024, pp. 1112-1123, https://doi.org/10.1182/blood.2023022526.